219 related articles for article (PubMed ID: 38646625)
1. Exploring of gut microbiota features in dyslipidemia and chronic coronary syndrome patients undergoing coronary angiography.
Luangphiphat W; Prombutara P; Muangsillapasart V; Sukitpunyaroj D; Eeckhout E; Taweechotipatr M
Front Microbiol; 2024; 15():1384146. PubMed ID: 38646625
[TBL] [Abstract][Full Text] [Related]
2. Associations of gut microbiota with dyslipidemia based on sex differences in subjects from Northwestern China.
Guo L; Wang YY; Wang JH; Zhao HP; Yu Y; Wang GD; Dai K; Yan YZ; Yang YJ; Lv J
World J Gastroenterol; 2022 Jul; 28(27):3455-3475. PubMed ID: 36158270
[TBL] [Abstract][Full Text] [Related]
3. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
[No Abstract] [Full Text] [Related]
4. Effect of DLT-SML on Chronic Stable Angina Through Ameliorating Inflammation, Correcting Dyslipidemia, and Regulating Gut Microbiota.
Zhao X; Chen Y; Li L; Zhai J; Yu B; Wang H; Yang D; Wang Q; Chang Y; Li J; Zhang P; Zhang H; Li Y
J Cardiovasc Pharmacol; 2021 Feb; 77(4):458-469. PubMed ID: 33657052
[TBL] [Abstract][Full Text] [Related]
5. Dysbiosis signatures of gut microbiota in coronary artery disease.
Zhu Q; Gao R; Zhang Y; Pan D; Zhu Y; Zhang X; Yang R; Jiang R; Xu Y; Qin H
Physiol Genomics; 2018 Oct; 50(10):893-903. PubMed ID: 30192713
[TBL] [Abstract][Full Text] [Related]
6. Subfractional Spectrum of Serum Lipoproteins and Gut Microbiota Composition in Healthy Individuals.
Kashtanova DA; Klimenko NS; Tkacheva ON; Strazhesko ID; Metelskaya VA; Gomyranova NV; Boytsov SA
Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361897
[No Abstract] [Full Text] [Related]
7. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
[TBL] [Abstract][Full Text] [Related]
8. The Prebiotic Effects of Oats on Blood Lipids, Gut Microbiota, and Short-Chain Fatty Acids in Mildly Hypercholesterolemic Subjects Compared With Rice: A Randomized, Controlled Trial.
Xu D; Feng M; Chu Y; Wang S; Shete V; Tuohy KM; Liu F; Zhou X; Kamil A; Pan D; Liu H; Yang X; Yang C; Zhu B; Lv N; Xiong Q; Wang X; Sun J; Sun G; Yang Y
Front Immunol; 2021; 12():787797. PubMed ID: 34956218
[TBL] [Abstract][Full Text] [Related]
9. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
10. Human Gut Microbiota in Coronary Artery Disease: A Systematic Review and Meta-Analysis.
Choroszy M; Litwinowicz K; Bednarz R; Roleder T; Lerman A; Toya T; Kamiński K; Sawicka-Śmiarowska E; Niemira M; Sobieszczańska B
Metabolites; 2022 Nov; 12(12):. PubMed ID: 36557203
[TBL] [Abstract][Full Text] [Related]
11. Microbial signature of plaque and gut in acute coronary syndrome.
Pisano E; Bugli F; Severino A; Pedicino D; Paroni Sterbini F; Martini C; De Maio F; Vinci R; Sacconi A; Canonico F; D'Aiello A; Bonanni A; Proto L; Ciampi P; Ponzo M; Grimaldi MC; Urbani A; Primiano A; Gervasoni J; Montone R; Crea F; Sanguinetti M; Liuzzo G
Sci Rep; 2023 Sep; 13(1):14775. PubMed ID: 37679428
[TBL] [Abstract][Full Text] [Related]
12. Alterations in the gut microbiome and metabolism with coronary artery disease severity.
Liu H; Chen X; Hu X; Niu H; Tian R; Wang H; Pang H; Jiang L; Qiu B; Chen X; Zhang Y; Ma Y; Tang S; Li H; Feng S; Zhang S; Zhang C
Microbiome; 2019 Apr; 7(1):68. PubMed ID: 31027508
[TBL] [Abstract][Full Text] [Related]
13.
Sayols-Baixeras S; Dekkers KF; Baldanzi G; Jönsson D; Hammar U; Lin YT; Ahmad S; Nguyen D; Varotsis G; Pita S; Nielsen N; Eklund AC; Holm JB; Nielsen HB; Ericson U; Brunkwall L; Ottosson F; Larsson A; Ericson D; Klinge B; Nilsson PM; Malinovschi A; Lind L; Bergström G; Sundström J; Ärnlöv J; Engström G; Smith JG; Orho-Melander M; Fall T
Circulation; 2023 Aug; 148(6):459-472. PubMed ID: 37435755
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gut microbiota in adults with coronary atherosclerosis.
Dong Y; Xu R; Chen X; Yang C; Jiang F; Shen Y; Li Q; Fang F; Li Y; Shen X
PeerJ; 2023; 11():e15245. PubMed ID: 37220524
[TBL] [Abstract][Full Text] [Related]
15. Guanxinning Tablet Attenuates Coronary Atherosclerosis via Regulating the Gut Microbiota and Their Metabolites in Tibetan Minipigs Induced by a High-Fat Diet.
Yang Q; Xu Y; Shen L; Pan Y; Huang J; Ma Q; Yu C; Chen J; Chen Y; Chen M
J Immunol Res; 2022; 2022():7128230. PubMed ID: 35935588
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota dysbiosis and decreased levels of acetic and propionic acid participate in glucocorticoid-induced glycolipid metabolism disorder.
Zhang Q; Guan G; Liu J; Hu W; Jin P
mBio; 2024 Feb; 15(2):e0294323. PubMed ID: 38226811
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota dysbiosis characterized by abnormal elevation of
Liang X; Li Y; Cheng L; Wu Y; Wu T; Wen J; Huang D; Liao Z; Tan C; Luo Y; Liu Y
Front Cell Infect Microbiol; 2023; 13():1243512. PubMed ID: 37692165
[TBL] [Abstract][Full Text] [Related]
18. Low-density lipoprotein triglyceride predicts outcomes in patients with chronic coronary syndrome following percutaneous coronary intervention according to inflammatory status.
Zhang HW; Guo YL; Wu NQ; Zhu CG; Dong Q; Sun J; Dou KF; Li JJ
Clin Chim Acta; 2023 Nov; 551():117631. PubMed ID: 37931732
[TBL] [Abstract][Full Text] [Related]
19. A Comparative Study of the Gut Microbiota Associated With Immunoglobulin a Nephropathy and Membranous Nephropathy.
Dong R; Bai M; Zhao J; Wang D; Ning X; Sun S
Front Cell Infect Microbiol; 2020; 10():557368. PubMed ID: 33194798
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome.
Zhang J; Luo D; Lin Z; Zhou W; Rao J; Li Y; Wu J; Peng H; Lou T
Microb Pathog; 2020 Oct; 147():104359. PubMed ID: 32599137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
